ArticleThoracic cancer2023

Clinical significance of interstitial lung abnormalities and immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.

Daiki Murata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.